参考文献/References:
[1] 张冀.建立中国罕见病医疗保障体系的几点探讨[J].哈尔滨医药,2014,34(2):85-86.
ZHANG J.Discussion on establishment of rare disease medical security system in China[J].Harbin Med J,2014,34(2):85-86.
[2] FIRE A,XU S Q,MONTGOMERY M K,KOSTAS S A,DRIVER S A.Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans[J].Nature,1998,391(6669):806-811.
[3] LAI Y K,SHARMA S,LAI C M,BRANKOV M,CONSTABLE I J,RAKOCZY P E.Virus-mediated secretion gene therapy--a potential treatment for ocular neovascularization[J].Adv Exp Med Biol,2003,533:447-453.
[4] YANG L,JIANG Y,WU S F,ZHOU M Y,WU Y L,CHEN G Q.CCAAT/enhancer-binding protein alpha antagonizes transcriptional activity of hypoxia-inducible factor 1 alpha with direct protein-protein interaction[J].Carcinogenesis,2008,29(2):291-298.
[5] RATNAPRIYA R,ZHAN X,FARISS R N,BRANHAM K,ZIPPRER D,CHAKAROVA C F,et al.Rare and common variants in extracellular matrix gene fibrillin 2 (FBN2) are associated with macular degeneration[J].Hum Mol Genet,2014,23(21):5827-5837.
[6] DUVVARI M R,VAN DE VEN J P,GEERLINGS M J,SAKSENS N T,BAKKER B,HENKES A,et al.Whole exome sequencing in patients with the cuticular drusen subtype of age-related macular degeneration[J].PLoS One,2016,11(3):e0152047.
[7] WONG C W,YANAGI Y,LEE W K,OGURA Y,YEO I,WONG T Y,et al.Age-related macular degeneration and polypoidal choroidal vasculopathy in Asians[J].Prog Retin Eye Res,2016,7(53):107-139.
[8] HOLZ F G,SADDA S R,BUSBEE B,CHEW E Y,MITCHELL P,TUFAIL A,et al.Efficacy and safety of lampalizumab for geographic atrophy due to age-related macular degeneration:chroma and spectri phase 3 randomized clinical trials[J].JAMA Ophthalmol,2018,136(6):666-677.
[9] ZHANG H,HU W,RAMIREZ F.Developmental expression of fibrillin genes suggests heterogeneity of extracellular microfibrils[J]. J Cell Biol,1995,129(4):1165-1176.
[10] YASUKAWA T,OGURA Y,TABATA Y,KIMURA H,WIEDEMANN P,HONDA Y.Drug delivery systems for vitreoretinal diseases[J]. Prog Retin Eye Res,2004,23:253-281.
[11] PENG Y,TANG L,ZHOU Y.Subretinal injection:a review on the novel route of therapeutic delivery for vitreoretinal diseases[J].Ophthalmic Res,2017,58(4):217-226.
[12] 徐福如,蒋文君,姜倩,张瑞雪,刘德政,毕宏生.原纤维蛋白-2(FBN2) 抗体玻璃体内注射对小鼠视网膜变性的影响[J].眼科新进展,2020,40(3):211-215.
XU F R,JIANG W J,JIANG Q,ZHANG R X,LIU D Z,BI H S.Effect of intravitreal injection of FBN2 antibody on retinal degeneration in mice[J].Rec Adv Ophthalmol,2020,40(3):211-215.
[13] CASTANOTTO D,ROSSI J J.The promises and pitfalls of RNA-interference-based therapeutics[J].Nature,2009,457(7228):426-433.
[14] LE G L,GOGAT K,BOUQUET C,SAINT-GENIEZ M,DARLAND D,VAN DEN BERGHE L,et al.In vivo adenovirus-mediated delivery of a uPA/uPAR antagonist reduces retinal neovascularization in a mouse model of retinopathy[J].Gene Ther,2003,10(25):2098-2103.
[15] BAKRI S J,SNYDER M R,REID J M,PULIDO J S,EZZAT M K,SINGH R J.Pharmacokinetics of intravitreal ranibizumab (Lucentis)[J].Ophthalmology,2007,114(12):2179-2182.
[16] SENGLE G,CARLBERG V,TUFA S F,CHARBONNEAU N L,SMALDONE S,CARLSON E J,et al.Abnormal activation of BMP signaling causes myopathy in FBN2 null mice[J].PLoS Genet,2015,11(6):e1005340.
[17] THOMPSON R B,REFFATTO V,BUNDY JG,KORTVELY E,FLINN J M,LANZIROTTI A,et al.Identification of hydroxyapatite spherules provides new insight into subretinal pigment epithelial deposit formation in the aging eye[J]. Proc Natl Acad Sci U S A,2015,112(5):1565-1570.
[18] BRUNNER M,HAUETER I,VALMAGGIA C.Dexamethason implant in the treatment of macular edema in retinal vein occlusion and intraocular inflammatory disease [J].Klin Monbl Augenheilkd,2013,230(4):396-400.
[19] 刘艳丽, 刘华, 李丽华.氢离子对碘酸钠诱导的小鼠年龄相关性黄斑变性视网膜的保护作用及机制[J].眼科新进展,2018,38(9):820-824.
LIU Y L,LIU H,LI L H.Protective effects of hydrogen ion on the retina of mice with age-related macular degeneration induced by sodium iodate and its mechanism[J].Rec Adv Ophthalmol,2018,38(9):820-824.
[20] 安娜,陈强,梁丽娜,庄曾渊.氢醌诱导小鼠年龄相关性黄斑变性模型的建立[J].眼科新进展,2016,36(7):605-608.
AN N,CHEN Q,LIANG L N,ZHUANG Z Y.Establishment of hydroquinone induced age-related macular degeneration model in mice[J].Rec Adv Ophthalmol,2016,36(7):605-608.
[21] TAO Y,DING L,YAO A.Intravitreous delivery of alphab-crystallin ameliorates N-Methyl-N-Nitrosourea induced photoreceptor degeneration in mice:an in vivo and ex vivo study[J].Cell Physiol Biochem,2018,48(5):2147-2160.
[22] 张海燕,李铁军,刘玉青,张习,王静娴,张敬一.光学相干断层扫描在老年黄斑变性诊断中的图像特征[J].中国医学装备,2016,13(12):96-98.
ZHANG H Y,LI T J,LIU Y Q,ZHANG X,WANG J X,ZHANG J Y.The image characteristics of optical coherence tomography in the diagnosis of senile macular degeneration[J].CHN Med Equi,2016,13(12):96-98.
[23] ROTH D A,KESSLER C M,PASI K J,RUP B,COURTER S G,TUBRIDY K L,et al.Human recombinant factor IX:safety and efficacy studies in hemophilia B patients previously treated with plasma-derived factor IX concentrates[J].Blood,2001,98(13):3600-3606.
[24] NATARAJAN S.Retinitis pigmentosa:a brief overview[J].Indian J Ophthalmol,2011,59(5):343-346.
[25] SUN Y J,MA S,FAN B,WANG Y,WANG S R,LI G Y.Therapeutic hypothermia protects photoreceptors through activating Cirbp pathway[J].Neurochem Int,2019,126:86-95.
[26] CURCIO C A,OWSLEY C,JACKSON G R.Spare the rods,save the cones in aging and age-related maculopathy[J].Invest Ophthalmol Vis Sci,2000,41(8):2015-2018.
[27] FALSINI B,SERRAO S,FADDA A,IAROSSI G,PORRELLO G,COCCO F,et al.Focal electroretinograms and fundus appearance in nonexudative age-related macular degeneration.Quantitative relationship between retinal morphology and function[J].Graefes Arch Clin Exp Ophthalmol,1999,237(3):193-200.
[28] 王宝英,胡成虎,俞小瑞.骨髓间充质干细胞(MSCs)对N-甲基-N-亚硝脲(MNU)诱导的C57BL小鼠视网膜变性的治疗作用 [J].眼科新进展,2017,37(9):810-815.
WANG B Y,HU C H,YU X R.Effect of bone marrow mesenchymal stem cells (MSCs) on retinal degeneration induced by N-methyl-N-nitrosuron (MNU) in C57BL mice[J].Rec Adv Ophthalmol,2017,37(9):810-815.
[29] MAUMENEE I H.The eye in the Marfan syndrome[J].Trans Am Ophthalmol Soc,1981,79:684-733.
[30] STREILEIN J W.Ocular immune privilege:therapeutic opportunities from an experiment of nature[J].Nat Rev Immunol,2003,3(11):879-889.
[31] KUMAR M,KELLER B,MAKALOU N,SUTTON R E.Systematic determination of the packaging limit of lentiviral vectors [J].Hum Gene Ther,2001,12(15):1893-1905.